Barriers and Facilitators to HIV Testing Among Women
Journal Title: HIV/AIDS Research and Treatment – Open Journal - Year 2018, Vol 0, Issue 1
Abstract
Aim: The purpose of this secondary analysis was to analyze for barriers and facilitators to HIV testing in women attending community health clinics. Introduction: The Centers for Disease Control and Prevention (CDC), reported that all women account for 20% or 1 in 5 of new HIV cases (CDC, 2012). Of those new cases in heterosexual women, 5,300 were Black, 1,300 were White, and 1,200 were Hispanic/Latina. The CDC estimated that in 2012 there were 9,268 individuals living with a diagnosis of HIV or AIDS, of which 19% were women. Results: The existing de-identified data consisted of thirty individual interviews conducted using a semi-structured interview guide was collected as the initial phase of the parent study, “HIV Testing and Women’s Attitudes on HIV Vaccine Trials”. This secondary analysis addressed the identification of key obstacles to HIV testing and only those related portions of the transcripts were analyzed. The major themes identified were familiarity with testing, stigma, fear, perceived risks, and access to care. Conclusion: The themes implicated the need to further assess women for barriers and facilitators to testing, tailor community based interventions that have the ability to decrease fear and stigma, increase trust in testing methods and offer counseling to positive results.
Authors and Affiliations
Graham J. McDougall Jr.
Keywords
Related Articles
- EP ID EP560714
- DOI 10.17140/HARTOJ-SE-1-102
- Views 125
- Downloads 0
HIV-Related Health Status, Adherence, and Stress Coping Capacity among Men Living with HIV in Japan
Object: The aim of this study was to ascertain the associations between human immunodeficiency virus (HIV)-related health status and stress coping capacity, and between adherence to taking medicine and stress-coping capa...
Perceptions of HIV-Associated Stigma in the U.S. Virgin Islands
Introduction: The U.S. Virgin Islands (USVI) has one of the highest HIV rates in the U.S. to date. In order to understand the high prevalence of HIV, it is important to identify the factors that contribute to HIV, especi...
Why Novel Nanoparticle-based Delivery Platforms Hold Key for HIV/AIDS Treatment and Prevention?
The administration of highly active antiretroviral therapy (HAART) to HIV/AIDS patients has greatly reduced their morbidity and mortality. However, HAART regimens have myriad of limitations, which make it difficult to co...
HIV/AIDS-Related Knowledge and Sources of Information among Secondary School Students in Enugu Nigeria
The present study aimed to evaluate AIDs – related knowledge, and sources of information, among secondary school students in Enugu, Nigeria. Anonymous structured interviews were conducted with 1009 multi-stage sampled st...
The Elderly are Facing HIV/AIDS Crisis
The world’s population is aging, and the population aged 60 or over is growing faster than all younger age groups globally. In 2017, there are an estimated 962 million people aged 60 or over in the world, comprising 13%...